Tackling challenges to end tuberculosis

Next week, world leaders will meet to take part in the first UN High Level Meeting on TB, in history. As QuantuMDx is the only UK company accredited to attend

Share
QuantuMDx announces executive appointments

  QuantuMDx Group Ltd today announced two key leadership appointments. Dr Allan Brown has been appointed Chief Operating Officer and David Matthews joins as Chief Financial Officer. “These appointments represent the

Share
QuantuMDx: 10 years and 1 incredible journey

To celebrate our 10th birthday this year, we’ve produced an infographic to chart our incredible journey, from a makeshift laboratory in a Sussex garage, to performance testing of our Q-POC™ 

Share
Staff Spotlight: Jennifer Hannant

We’re launching a new ‘Staff Spotlight’ feature: a Q&A with members of Team QuantuMDx to gain an insight into their role, career highlights and ambitions. This month we’ve interviewed Jennifer

Share
The Consul General of India visits QuantuMDx

The Consul General of India, Dr Aman Puri, visited Newcastle upon Tyne yesterday which included a tour of laboratories at QuantuMDx Group Limited (QuantuMDx). As a life science tools and diagnostics company, QuantuMDx

Share
QuantuMDx achieves ISO 13485: 2016 certification

QuantuMDx Group has been awarded ISO 13485: 2016 certification – representing the highest standard of quality a medical devices company can achieve. ISO 13485 is a quality system standard designed

Share
World TB Day: Engaging end users when developing diagnostics

To coincide with World TB Day, Mark Ware, Patient Engagement and Training Manager at QuantuMDx, highlights the importance of end user engagement when devising point of care diagnostic tools for infectious

Share
QuantuMDx raises $12m and strengthens Board as company eyes commercialisation of Q-POC™ portable MDx platform

Newcastle upon Tyne, UK – 23 January 2018 Life science tools and diagnostics company QuantuMDx announced today it has closed a $12m funding round. As part of this round it

Share